In CKD, a similarly intricate network is observed as in AKI, where the downregulation of critical genes such as CPT1a, PGC-1α, and KLFs further impairs FAO, contributing to renal fibrosis and dysfunction. This evidence concerns the gene CPT1A and chronic kidney disease.